Search our Site
Current Edition:
Table of Contents :
Editor's note
Neil Love, MD
Section 1
Breast cancer in the elderly
Section 2
Risks and benefits of capecitabine in metastatic disease
Section 3
Clinical decision-making in metastatic breast cancer
Section 4
Randomized trial of docetaxel-capecitabine vs docetaxel
Section 5
Clinical use of aromatase inhibitors
Section 6
Clinical trials with anti-angiogenic agents
Section 7
Complementary and alternative medicine
Section 8
Psychosocial issues in breast cancer management
Contact information, list of pharmaceutical agents
Contact Us
About Us
Terms of use and general disclaimer
Home
·
Contact us
Terms of use and general disclaimer
© NL Communications, Inc. 2003. All rights reserved.
